These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22920680)

  • 1. Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma.
    Pedicini P; Nappi A; Strigari L; Jereczek-Fossa BA; Alterio D; Cremonesi M; Botta F; Vischioni B; Caivano R; Fiorentino A; Improta G; Storto G; Benassi M; Orecchia R; Salvatore M
    Radiat Oncol; 2012 Aug; 7():143. PubMed ID: 22920680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimate of the accelerated proliferation by protein tyrosine phosphatase (PTEN) over expression in postoperative radiotherapy of head and neck squamous cell carcinoma.
    Pedicini P; Fiorentino A; Improta G; Nappi A; Salvatore M; Storto G
    Clin Transl Oncol; 2013 Nov; 15(11):919-24. PubMed ID: 23460560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.
    Nijkamp MM; Span PN; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende PL; de Jong M; van der Kogel AJ; Bussink J; Kaanders JH
    Eur J Cancer; 2013 Oct; 49(15):3202-9. PubMed ID: 23867129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
    Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck.
    Eriksen JG; Steiniche T; Askaa J; Alsner J; Overgaard J
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):561-6. PubMed ID: 14751528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen.
    Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Guenzi M; Margarino G; Bacigalupo A; Garaventa G; Barbieri M
    J Clin Oncol; 1995 Aug; 13(8):1843-50. PubMed ID: 7636527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
    Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
    J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma.
    Chung CH; Zhang Q; Hammond EM; Trotti AM; Wang H; Spencer S; Zhang HZ; Cooper J; Jordan R; Rotman MH; Ang KK
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):331-8. PubMed ID: 20732768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways.
    Pickhard AC; Margraf J; Knopf A; Stark T; Piontek G; Beck C; Boulesteix AL; Scherer EQ; Pigorsch S; Schlegel J; Arnold W; Reiter R
    BMC Cancer; 2011 Sep; 11():388. PubMed ID: 21896192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
    Bourhis J; Dendale R; Hill C; Bosq J; Janot F; Attal P; Fortin A; Marandas P; Schwaab G; Wibault P; Malaise EP; Bobin S; Luboinski B; Eschwege F; Wilson G
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):471-6. PubMed ID: 8655369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck.
    Tinhofer I; Hristozova T; Stromberger C; Keilhoiz U; Budach V
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e685-90. PubMed ID: 22583603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study.
    Eriksen JG; Steiniche T; Overgaard J;
    Radiother Oncol; 2005 Feb; 74(2):93-100. PubMed ID: 15816106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell kinetics and tumor regression during radiotherapy in head and neck squamous-cell carcinomas.
    Corvò R; Giaretti W; Geido E; Sanguineti G; Orecchia R; Scala M; Garaventa G; Mora E; Vitale V
    Int J Cancer; 1996 Oct; 68(2):151-5. PubMed ID: 8900419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer.
    Argiris A; Duffy AG; Kummar S; Simone NL; Arai Y; Kim SW; Rudy SF; Kannabiran VR; Yang X; Jang M; Chen Z; Suksta N; Cooley-Zgela T; Ramanand SG; Ahsan A; Nyati MK; Wright JJ; Van Waes C
    Clin Cancer Res; 2011 Sep; 17(17):5755-64. PubMed ID: 21750205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy].
    Corvò R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Franzone P; Mereu P; Garaventa G; Barbieri M; Vitale V
    Radiol Med; 1993; 86(1-2):135-42. PubMed ID: 8346344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
    Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
    World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the diagnosis and treatment of cancer located in the head and neck and correlation with expression of prognostic markers.
    Bădulescu F; Bădulescu A; Crişan A; Popescu FC
    Rom J Morphol Embryol; 2013; 54(3):487-97. PubMed ID: 24068395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
    Eriksen JG; Steiniche T; Overgaard J;
    Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.